Address
Surrey Technology Centre
Guildford, GU2 7YG
United Kingdom of Great Britain and Northern Ireland (the)
Phone
44 14 8368 5670
Sector
Healthcare
Industry
Biotechnology
Employees
14
First IPO Date
July 22, 2003
| Name | Title | Pay | Year Born |
| Alex Duggan | Chief Executive Officer & Executive Director | 297,620 | N/A |
| Alexander James Hanbury Duggan | Chief Executive Officer & Executive Director | 297,620 | 1970 |
| Kenneth William James | Head of R&D & Executive Director | 218,400 | 1952 |
| Angela Hildreth | Chief Operating Officer, Finance Director, Company Secretary & Executive Director | 227,414 | 1980 |
| William Duncan Potter | Chief Scientific Officer & Adviser to the Board | 0 | 1948 |
| Graham Smith | Head of Alliance Partnerships & Supply | 0 | N/A |
| Kevin Langridge | Head of Quality | 0 | N/A |
Futura Medical plc operates as a pharmaceutical firm specializing in the creation and advancement of consumer healthcare products. The company primarily targets the sexual health and pain management sectors. Its leading innovation is MED3000, a topical gel specifically formulated to treat erectile dysfunction. Additionally, Futura Medical offers a variety of pain relief solutions, including TPR100, a topical diclofenac gel; CBD100, a cannabidiol-based topical application; and TIB200, an ibuprofen topical gel. Established in 2001, the company is headquartered in Guildford, United Kingdom.